Resources Contact Us Home
Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis

Image Number 15 for United States Patent #7285268.

The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same.

  Recently Added Patents
Interleaving charge pumps for programmable memories
Method and system for reduction of decoding complexity in a communication system
Method and system for streaming digital video content to a client in a digital video network
Image forming apparatus and method of translating virtual memory address into physical memory address
Provision of downlink packet access services to user equipment in spread spectrum communication network
Emergency call notification for network services
Process for the production of an acylation catalyst
  Randomly Featured Patents
Methods for analyzing ion mobility data
Production of perforated metal foil
Headmount apparatus for attaching and supporting devices
Method of making a voltage responsive switch
Mixing vane protecting flap
Charge transport layers containing purified polycarbonates
Dielectric filter having notch pattern
Multi-part mailer form assembly
Device for adjusting the preload of a plate spring for an optical pickup apparatus